Physician profile
David S Eingorn
NPI 1821094723
$7,169.98
in general payments reported to CMS, 2019-2025
18 companies · $80.24 in 2025
The $80.24 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,311 · 2020: $79.65 · 2021: $27.20 · 2022: $197 · 2023: $373 · 2024: $103 · 2025: $80.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $555.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $5,650.00 | 2019 | |
| Stryker Corporation | $479.15 | 2019-2024 | Gamma, Prophecy, Sonicpin |
| Pacira Therapeutics, INC. | $280.80 | 2019-2020 | |
| Depuy Synthes Sales INC. | $193.95 | 2019-2023 | Orthovisc |
| Heraeus Medical, LLC. | $86.71 | 2019-2025 | Palacos |
| Exactech, INC. | $68.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $57.55 | 2019-2022 | |
| Zimmer Biomet Holdings, INC. | $55.83 | 2021-2022 | |
| Bioventus LLC | $50.79 | 2022 | |
| Smith+Nephew, INC. | $49.11 | 2019-2024 | Pico 14 |
| Biocomposites INC | $48.58 | 2025 | Stimulan |
| Ferring Pharmaceuticals INC. | $41.58 | 2020-2025 | Euflexxa |
| Supreme Orthopedic Systems, LLC | $26.98 | 2024 | |
| Boston Scientific Corporation | $22.13 | 2024 | |
| Avanos Medical | $19.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $15.44 | 2019 | |
| Horizon Therapeutics Plc | $12.50 | 2019 | |
| Iroko Pharmaceuticals, LLC | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Eingorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.